Literature DB >> 28548139

Clinician's Commentary on Choi et al.1.

Parvin Eftekhar1.   

Abstract

Mesh：

Year:  2017        PMID： 28548139      PMCID： PMC5435399          DOI： 10.3138/ptc.2016-25-CC

Source DB:  PubMed          Journal:  Physiother Can        ISSN： 0300-0508            Impact factor:   1.037


× No keyword cloud information.
  8 in total

1.  Linking health-status measurements to the international classification of functioning, disability and health.

Authors:  Alarcos Cieza; Thomas Brockow; Thomas Ewert; Edda Amman; Barbara Kollerits; Somnath Chatterji; T Berdihan Ustün; Gerold Stucki
Journal:  J Rehabil Med       Date:  2002-09       Impact factor: 2.912

2.  Goal attainment for spasticity management using botulinum toxin.

Authors:  Stephen Ashford; Lynne Turner-Stokes
Journal:  Physiother Res Int       Date:  2006-03

Review 3.  Spasticity: clinical perceptions, neurological realities and meaningful measurement.

Authors:  A D Pandyan; M Gregoric; M P Barnes; D Wood; F Van Wijck; J Burridge; H Hermens; G R Johnson
Journal:  Disabil Rehabil       Date:  2005 Jan 7-21       Impact factor: 3.033

4.  Goal attainment scaling in the evaluation of treatment of upper limb spasticity with botulinum toxin: a secondary analysis from a double-blind placebo-controlled randomized clinical trial.

Authors:  Lynne Turner-Stokes; Ian J Baguley; Stephen De Graaff; Pesi Katrak; Leo Davies; Paul McCrory; Andrew Hughes
Journal:  J Rehabil Med       Date:  2010-01       Impact factor: 2.912

Review 5.  Treatment of upper extremity spasticity in stroke patients by focal neuronal or neuromuscular blockade: a systematic review of the literature.

Authors:  A A van Kuijk; A C H Geurts; B J W Bevaart; J van Limbeek
Journal:  J Rehabil Med       Date:  2002-03       Impact factor: 2.912

6.  Goal Attainment Scaling in Individuals with Upper Limb Spasticity Post Stroke.

Authors:  Parvin Eftekhar; George Mochizuki; Tilak Dutta; Denyse Richardson; Dina Brooks
Journal:  Occup Ther Int       Date:  2016-10-03       Impact factor: 1.448

7.  Effect of baseline spastic hemiparesis on recovery of upper-limb function following botulinum toxin type A injections and postinjection therapy.

Authors:  Chia-Lin Chang; Michael C Munin; Elizabeth R Skidmore; Christian Niyonkuru; Lynne M Huber; Douglas J Weber
Journal:  Arch Phys Med Rehabil       Date:  2009-09       Impact factor: 3.966

8.  Goal attainment following upper-limb botulinum toxin-A injections: are we facilitating achievement of client-centred goals?

Authors:  Melissa T Nott; Hannah L H Barden; Ian J Baguley
Journal:  J Rehabil Med       Date:  2014-10       Impact factor: 2.912
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.